HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 208 filers reported holding HAEMONETICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $16,483,000 | -75.5% | 148,480 | -73.8% | 0.58% | -77.5% |
Q4 2020 | $67,256,000 | -53.1% | 566,370 | -60.6% | 2.59% | -57.7% |
Q1 2020 | $143,347,000 | +131.5% | 1,438,356 | +166.9% | 6.13% | +177.4% |
Q4 2019 | $61,927,000 | +131.9% | 538,962 | +154.6% | 2.21% | +118.9% |
Q3 2019 | $26,700,000 | -36.6% | 211,670 | -39.6% | 1.01% | -38.3% |
Q2 2019 | $42,142,000 | -64.5% | 350,190 | -74.2% | 1.64% | -65.9% |
Q1 2019 | $118,746,000 | +7.9% | 1,357,410 | +23.4% | 4.80% | +39.4% |
Q4 2018 | $110,069,000 | +221.0% | 1,100,140 | +267.6% | 3.44% | +202.6% |
Q3 2018 | $34,287,000 | -5.8% | 299,239 | -39.8% | 1.14% | -8.2% |
Q1 2018 | $36,391,000 | -56.8% | 497,410 | -65.7% | 1.24% | -54.8% |
Q4 2017 | $84,216,000 | +29.2% | 1,450,000 | -0.2% | 2.74% | +25.5% |
Q3 2017 | $65,167,000 | -11.0% | 1,452,343 | -21.7% | 2.18% | -17.4% |
Q2 2017 | $73,249,000 | +12.8% | 1,854,872 | +15.9% | 2.64% | -11.2% |
Q1 2017 | $64,912,000 | +40.4% | 1,600,000 | +39.1% | 2.98% | +14.0% |
Q4 2016 | $46,230,000 | – | 1,150,000 | – | 2.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |